Leptospirosis Clinical Stages
Leptospirosis follows a classic biphasic course consisting of an initial bacteremic (septicemic) phase lasting 4-7 days with flu-like symptoms, followed 1-3 days later by an immune phase characterized by fever, severe calf myalgia, and potential progression to hepatorenal syndrome and hemorrhage. 1
Stage 1: Bacteremic (Septicemic) Phase
Timing and Clinical Features
- Duration: 4-7 days after incubation period (7-12 days, range 2-30 days) 1
- Presentation: Non-specific flu-like illness with fever, myalgia (particularly calves), headache, and conjunctival suffusion (highly suggestive finding) 1
- Severity spectrum: Ranges from mild self-limiting illness to early signs of severe disease 1
Management During Bacteremic Phase
Initiate antibiotics immediately upon clinical suspicion—do not wait for laboratory confirmation given the non-specific nature of initial investigations. 1
For mild disease:
- Penicillin or tetracycline antibiotics (doxycycline) are effective during this phase 1
- Early treatment (within first 4 days) is critical for effectiveness 2
For severe/suspected Weil's disease:
- Injectable beta-lactams, primarily cephalosporins 3
- Treatment remains indicated even though severe disease is likely immunologically mediated 1
Diagnostic Approach in Phase 1
- Blood cultures should be obtained within first 5 days before antibiotics, kept at room temperature 1
- CSF cultures if meningeal signs present
- Initial labs are non-specific but look for: polymorphonuclear leukocytosis, thrombocytopenia, proteinuria, hematuria 1
- Serology typically negative this early (becomes positive 6-10 days after symptom onset) 1
Stage 2: Immune Phase
Timing and Clinical Features
- Onset: 1-3 days after initial phase resolves 1
- Key manifestations:
Severe Disease (Weil's Disease)
Occurs in 5-10% of infected patients 5 and includes:
- Jaundice with hepatorenal syndrome
- Hemorrhage (due to capillary fragility, not coagulopathy—clotting tests often normal) 1
- Renal failure (high bilirubin with mild transaminase elevation) 1
- Pulmonary involvement (20-70% of cases, can progress to ARDS) 5
Management During Immune Phase
Continue antibiotics despite the immune-mediated nature of severe disease—most infectious disease specialists recommend this approach even though systematic reviews show limited benefit in established severe leptospirosis. 1
- Patients with Weil's disease require intensive supportive care
- Renal replacement therapy may be necessary
- Liver support as indicated
- Monitor for respiratory complications requiring mechanical ventilation 1
Critical Clinical Predictors of Severe Disease
Watch for these red flags that predict progression to severe leptospirosis 6:
- Dyspnea (respiratory involvement)
- Oliguria (renal failure developing)
- Hemorrhagic symptoms (capillary fragility)
- Jaundice (Weil's disease)
- Hypotension (circulatory collapse)
Additional laboratory markers suggesting severe disease 3:
- Thrombocytopenia
- Cholestasis pattern
- Rhabdomyolysis
- Markedly elevated CRP
Diagnostic Confirmation
Serology is the primary diagnostic method:
- IgM titer >1:320 is suggestive of leptospirosis 1
- Titer 1:80 to 1:160 consistent with early infection but may represent cross-reactions 1
- Convalescent serology >10 days after symptom onset: IgM ELISA and microscopic agglutination test (MAT) for confirmation 1
Important pitfall: Urine is NOT suitable for isolation of leptospira 1
Key Management Principles
Treat empirically based on exposure history (fresh-water contact, animal exposure, flooding) and clinical presentation—do not delay for laboratory confirmation 1
Timing is critical: Antibiotic effectiveness depends on early initiation, ideally before day 4 of illness 2
Most patients recover completely without residual organ impairment, even those with severe disease 4
The biphasic nature is characteristic but not universal—some patients present directly with severe disease without a clear two-phase pattern 3